Choose the brand aligned with your industry so we can best serve your needs.
The cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B.
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
Rapidly detect and differentiation between SARS-CoV-2, Flu A, and Flu B from one sample on one assay in 15 minutes with the newest BD Veritor assay.
Promotional kit for rapid detection and differentiation of SARS-CoV-2 and Influenza
The TaqPath COVID-19, Flu A, Flu B Combo Kit includes the assays and controls for a multiplex real-time RT-PCR test for the qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A, and influenza B viruses in nasopharyngeal and anterior nasal swabs from individuals suspected of COVID-19 by their healthcare provider.
Lucira offers a PCR-quality molecular test for Covid and flu to speed accurate patient diagnosis anywhere at the point-of-care. With positive results in as little as 11 minutes and negative results in 30 minutes, patients can be diagnosed in-visit, helping to get your patients to better, faster.